Exploring-new-ingredient

This study demonstrates the benefits of a DC maltitol and sucralose combination for use in the formulation of paediatric acetaminophen chewable tablets with improved taste.

Acetaminophen is a common ingredient used to treat infants for pain and fever but its bitterness can be a problem. Recent studies of acetaminophen bitterness in paediatric chewable tablets carried out by experts at Roquette have revealed the surprisingly effective taste-masking synergy of the combination of maltitol with an intense sweetener.

Exploring new ingredient

Numerous technologies are available to mask the bitterness of APIs but their use in paediatric formulation is limited by the excipient’s toxicity, which is different for children compared with adults.

So there is a need for formulation based on simple and well-known excipients.

Numerous technologies are available to mask the bitterness of APIs but their use in paediatric formulation is limited by the excipient’s toxicity, which is different for children compared with adults. So there is a need for formulation based on simple and well-known excipients.

Acetaminophen or paracetamol is one of the most common medications used to treat infants for pain and fever. Its bitterness often leads to complex formulations, needed to improve acceptability by a child’s palate. While testing several directly compressible (DC) excipients in a first study on the formulation of chewable acetaminophen tablets containing sucralose, it was observed that all DC polyols were able to give a pleasant texture, but surprisingly some formulations based on (directly compressible maltitol from Roquette SweetPearl P300DC) were judged less bitter.

Therefore, masking the bitterness of acetaminophen by incorporating only a well-accepted intense sweetener (sucralose) and a bulk sweetener (maltitol), both of which are commonly used in paediatric medicines, is of significant interest.

Reproduced courtesy of Manufacturing Chemist - December 2015/January 2016

Recommended posts
  • September 13, 2017 Food nutrition FI ASIA 2017
  • September 12, 2017 Animal nutrition SPACE 2017
  • September 05, 2017 Industries - Paper and board PTS Coating Symposium 2017
  • July 30, 2017 Industries - Bio-industry SMIB 2017
  • July 12, 2017 Industries PTS Coating Symposium 2017
  • June 30, 2017 Animal - Petfood Roquette University pet food
  • June 23, 2017 Pharma - Oral dosage forms Case study: Advantages of film coating with a novel modified starch (disintegration time, dissolution profile)
  • June 19, 2017 Industries How to reduce your costs and improve your profitability with plant-based ingredients…
  • June 07, 2017 Corporate Roquette invests €40 million in France to reinforce its global leadership in pea protein
  • June 07, 2017 Corporate Roquette invests €40 million in France to reinforce its global leadership in pea protein
  • June 06, 2017 Corporate “Acting and investing sustainably now makes sense more than ever!”
  • June 06, 2017 Pharma Expanding what’s possible with the right partner
  • May 31, 2017 Corporate Roquette signs agreement to acquire Itacel and reinforce its global leadership in the pharmaceutical industry.
  • May 31, 2017 Corporate Roquette signs agreement to acquire Itacel and reinforce its global leadership in the pharma industry.
  • May 26, 2017 Food nutrition Roquette showcased new food concepts inspired by consumer insights at Vitafoods 2017.
  • May 22, 2017 Food nutrition Roquette to feature latest innovations in Proteins, Fibers and Sugar Reduction
Our site uses cookies for web statistics usage and to enhance your user experience. For more information visit our cookie policy and learn how to customize cookies setting.
Click Agree to accept cookies and go directly to the site.
Please, turn your device to portrait mode.